EZH2 and central nervous system cancer: These findings demonstrated that MSC-derived exosomes transferring miR-133b into glioma cells could potentially inhibit EZH2 expression by blocking the Wnt/β-catenin signaling pathway, thereby suppressing glioma cell proliferation, migration, and invasion [103].